OpenURL Connection Search

Select item for more details and to access through your institution.

SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.
Published in:
Carcinogenesis, 2024, v. 45, n. 1/2, p. 35, doi. 10.1093/carcin/bgad075
By:
- Rajanala, Sai Harisha;
- Plym, Anna;
- Vaselkiv, Jane B;
- Ebot, Ericka M;
- Matsoukas, Konstantina;
- Lin, Zhike;
- Chakraborty, Goutam;
- Markt, Sarah C;
- Penney, Kathryn L;
- Lee, Gwo-Shu M;
- Mucci, Lorelei A;
- Kantoff, Philip W;
- Stopsack, Konrad H
Publication type:
Article
Association of genetic variation of the six gene prognostic model for castration‐resistant prostate cancer with survival.
Published in:
Prostate, 2019, v. 79, n. 1, p. 73, doi. 10.1002/pros.23712
By:
- Xie, Wanling;
- Stopsack, Konrad H.;
- Drouin, Sarah J.;
- Fu, Henry;
- Pomerantz, Mark M.;
- Mucci, Lorelei A.;
- Lee, Gwo‐Shu M.;
- Kantoff, Philip W.
Publication type:
Article
Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.
Published in:
Integrative Biology, 2014, v. 6, n. 4, p. 388, doi. 10.1039/c3ib40264a
By:
- Xiaosai Yao;
- Choudhury, Atish D.;
- Yamanaka, Yvonne J.;
- Adalsteinsson, Viktor A.;
- Gierahn, Todd M.;
- Williamson, Christina A.;
- Lamb, Carla R.;
- Taplin, Mary-Ellen;
- Nakabayashi, Mari;
- Chabot, Matthew S.;
- Tiantian Li;
- Lee, Gwo-Shu M.;
- Boehm, Jesse S.;
- Kantoff, Philip W.;
- Hahn, William C.;
- Wittrup, K. Dane;
- Love, J. Christopher
Publication type:
Article
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Published in:
Prostate, 2021, v. 81, n. 10, p. 683, doi. 10.1002/pros.24148
By:
- Wang, Victoria;
- Geybels, Milan S.;
- Jordahl, Kristina M.;
- Gerke, Travis;
- Hamid, Anis;
- Penney, Kathryn L.;
- Markt, Sarah C.;
- Freedman, Matthew;
- Pomerantz, Mark;
- Lee, Gwo‐Shu M.;
- Rana, Huma;
- Börnigen, Daniela;
- Rebbeck, Timothy R.;
- Huttenhower, Curtis;
- Eeles, Ros A.;
- Stanford, Janet L.;
- Consortium, Practical;
- Berndt, Sonja I.;
- Claessens, Frank;
- Sørensen, Karina D.
Publication type:
Article
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Published in:
Prostate, 2021, v. 81, n. 10, p. 683, doi. 10.1002/pros.24148
By:
- Wang, Victoria;
- Geybels, Milan S.;
- Jordahl, Kristina M.;
- Gerke, Travis;
- Hamid, Anis;
- Penney, Kathryn L.;
- Markt, Sarah C.;
- Freedman, Matthew;
- Pomerantz, Mark;
- Lee, Gwo‐Shu M.;
- Rana, Huma;
- Börnigen, Daniela;
- Rebbeck, Timothy R.;
- Huttenhower, Curtis;
- Eeles, Ros A.;
- Stanford, Janet L.;
- Consortium, Practical;
- Berndt, Sonja I.;
- Claessens, Frank;
- Sørensen, Karina D.
Publication type:
Article

Found: 5

SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.

Association of genetic variation of the six gene prognostic model for castration‐resistant prostate cancer with survival.

Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.

A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.

A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.